Amphastar Pharmaceuticals Inc vs Target Corporation — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Target Corporation trades at $153 (market cap $69.17B). The key difference: Target Corporation is far larger — about 79.6× Amphastar Pharmaceuticals Inc's market cap, and Target Corporation pays a 3.05% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | TGT | |
|---|---|---|
Market Cap | $868.62M | $69.17B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $152.35 |
52-Week Low | $16.87 | $83.68 |
Enterprise Value | $1.27B | $84.47B |
Dividend Yield | — | 3.05% |
Trailing returns across standard periods
Latest headlines on both assets
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →